文献速递肾移植

肾移植受者胃肠道症状与生活质量的相关性

Patient-Reported Gastrointestinal Symptoms and the Association With Quality of Life Following Kidney Transplantation.
PubMed 文献 · Kidney Int Rep · 2020-10-24

该研究通过问卷评估343例肾移植受者,发现88%报告至少1种胃肠道症状,最常见为消化不良(57%)和腹泻(54%),42%和38%分别报告轻度与中度生活质量受损,女性及使用麦考酚酯是预测因素,且胃肠道症状与较差生活质量独立相关。

要点

  • 肾移植受者胃肠道症状常见,消化不良和腹泻最常见。
  • 女性及使用麦考酚酯者胃肠道症状更严重。
  • 胃肠道症状与生活质量受损独立相关。

核心结论

  • 肾移植受者中胃肠道症状常见,且与较差的生活质量相关。
  • 女性及使用麦考酚酯是胃肠道症状的预测因素。

研究设计与样本

  • 单中心研究纳入343例慢性肾移植受者,使用GIQLI、GSRS和SAGIS问卷评估。
  • 采用线性回归分析胃肠道症状及生活质量的预测因素。

主要发现

  • 中位年龄47岁,男性58%,白人79%,慢性肾小球肾炎39%,首次移植83%,移植后中位时间6.3年。
  • GSRS显示88%报告至少1种胃肠道症状,最常见消化不良57%和腹泻54%。
  • GIQLI显示42%轻度生活质量受损,38%中度受损。
  • 女性(系数-0.11,95%CI -0.21至-0.02)和麦考酚酯(系数0.0001,95%CI 0.0001至0.0002)预测胃肠道症状。
  • 胃肠道症状与较差生活质量相关(系数-0.38,95%CI -0.45至-0.30)。

关键数值与推荐

  • GSRS报告至少1种胃肠道症状者占88%,消化不良57%,腹泻54%。
  • GIQLI报告轻度生活质量受损占42%,中度占38%。
  • 女性与胃肠道症状的回归系数为-0.11(95%CI -0.21至-0.02)。
  • 麦考酚酯与胃肠道症状的回归系数为0.0001(95%CI 0.0001至0.0002)。
  • 胃肠道症状与生活质量的回归系数为-0.38(95%CI -0.45至-0.30)。

临床怎么用

  • 对肾移植受者应常规筛查胃肠道症状,尤其女性和使用麦考酚酯者。
  • 管理胃肠道症状可能有助于改善生活质量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There has been limited study of the prevalence of gastrointestinal symptoms and their impact on the quality of life (QOL) in kidney transplant recipients. The aim of this study was to examine the prevalence and predictors of gastrointestinal symptoms and the association with QOL in kidney transplant recipients. METHODS: All chronic kidney transplant recipients at the Princess Alexandra Hospital were provided with 3 questionnaires, the Gastrointestinal Quality of Life Index (GIQLI), the Gastrointestinal Symptoms Rating Scale (GSRS), and Structured Assessment of Gastrointestinal Symptoms (SAGIS) scale, to ascertain QOL impairment and to screen gastrointestinal symptom severity. Linear regression was used to determine the predictors of gastrointestinal QOL and gastrointestinal symptom severity. RESULTS: Of the 343 participants, the median age was 47 (interquartile range [IQR] 36-55) years, 58% were men, 79% were white, 39% had chronic glomerulonephritis, 83% had received their first graft, and median time since transplant was 6.3 (IQR 1.8-13.1) years. Using GSRS, 88% of participants reported at least 1 gastrointestinal symptom, most commonly indigestion (57%) and diarrhea (54%). Using GIQLI, 42% and 38% of participants reported mild and moderate QOL impairment, respectively. Gastrointestinal symptoms were predicted by female sex (coefficient -0.11, 95% CI -0.21 to -0.02) and mycophenolate (coefficient 0.0001, 95% CI 0.0001 to 0.0002), and were associated with poorer QOL (coefficient -0.38, 95% CI -0.45 to -0.30). Similar findings were observed using SAGIS for gastrointestinal symptoms. CONCLUSIONS: Gastrointestinal symptoms are frequent in kidney transplant recipients, particularly in women and those receiving mycophenolate, and are strongly associated with poorer QOL.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Chan S, Cao C, Pascoe EM, et al. Patient-Reported Gastrointestinal Symptoms and the Association With Quality of Life Following Kidney Transplantation. Kidney Int Rep. 2020. PMID: 33426393. doi:10.1016/j.ekir.2020.10.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。